11:22 AM EST - Revive Therapeutics Ltd : Has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation of cannabidiol for the treatment of autoimmune hepatitis, a rare liver disease. Revive Therapeutics Ltd
shares V.RVV are trading up $0.02 at $0.20.
